Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT2 | P31751 | 9/20 | 0.43 |
| ▸ | AKT1 | P31749 | 8/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.34 |
| ▸ | BACE1 | P56817 | 1/20 | 0.34 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.34 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.34 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.34 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25789319 | 0.92 | AKT1 (0.44) | AKT2AKT1HSP90AA1HSP90AB1NPC1 | |
| SCHEMBL25789148 | 0.91 | AKT2 (0.43) | AKT2AKT1HSP90AA1HSP90AB1NPC1 | |
| SCHEMBL13599930 | 0.91 | AKT2 (0.52) | AKT2AKT1HSP90AA1HSP90AB1NPC1 | |
| SCHEMBL13599927 | 0.91 | AKT2 (0.52) | AKT2AKT1HSP90AA1HSP90AB1NPC1 | |
| SCHEMBL25789261 | 0.90 | AKT1 (0.47) | AKT2AKT1HSP90AA1HSP90AB1NPC1 | |
| SCHEMBL25789973 | 0.90 | AKT2 (0.50) | AKT2AKT1HSP90AA1HSP90AB1NPC1 | |
| SCHEMBL13599931 | 0.90 | AKT2 (0.50) | AKT2AKT1HSP90AA1HSP90AB1NPC1 | |
| SCHEMBL25789286 | 0.87 | AKT1 (0.41) | AKT2AKT1HSP90AA1HSP90AB1NPC1 | |
| SCHEMBL13599926 | 0.87 | AKT2 (0.43) | AKT2AKT1HSP90AA1HSP90AB1NPC1 | |
| SCHEMBL13599929 | 0.87 | RAB9A (0.45) | AKT2AKT1HSP90AA1HSP90AB1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230217820-A1 | PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) | 2023-07-06 | — | — | US | disclosed |
| US-20230217820-A1 | PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230217820-A1 | PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | TELO2, SOD1, TERT | AKT2 3327/4885AKT1 2890/4885HSP90AA1 1856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.